Resultados de procura - H Kumada

  • Mostrando 1 - 9 Resultados de 9
Limitar resultados
  1. 1
    Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis

    Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis por H. Kumada, Yuji Haishima, Tomoyuki Umemoto, Ken‐ichi Tanamoto

    Publicado 1995
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Efficacy and safety of telaprevir, a new protease inhibitor, for difficult‐to‐treat patients with genotype 1 chronic hepatitis C

    Efficacy and safety of telaprevir, a new protease inhibitor, for difficult‐to‐treat patients with genotype 1 chronic hepatitis C por Norio Hayashi, Takeshi Okanoue, Hirohito Tsubouchi, J. Toyota, Kazuaki Chayama, H. Kumada

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Inflammatory cytokine gene expression in human periodontal ligament fibroblasts stimulated with bacterial lipopolysaccharides

    Inflammatory cytokine gene expression in human periodontal ligament fibroblasts stimulated with bacterial lipopolysaccharides por Yoshikazu Yamaji, Takao Kubota, Kenichi Sasaguri, Shigeo Sato, Y. Suzuki, H. Kumada, Tomoyuki Umemoto

    Publicado 1995
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues

    Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expressio... por Shigemasa Hanazawa, Yasuhiro Kawata, Akira Takeshita, H. Kumada, M Okithu, Susumu Tanaka, Yuko Yamamoto, T. Masuda, Tomoyuki Umemoto, S Kitano

    Publicado 1993
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C

    A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C por Masao Omata, Haruhiko Yoshida, J. Toyota, Eiichi Tomita, S. Nishiguchi, Norio Hayashi, S Iino, Isao Makino, K Okita, G Toda, K Tanikawa, H. Kumada

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Two Subtypes of Genotype B (Ba and Bj) of Hepatitis B Virus in Japan

    Two Subtypes of Genotype B (Ba and Bj) of Hepatitis B Virus in Japan por Fuminaka Sugauchi, H Kumada, Hiroshi Sakugawa, Masashi Komatsu, Hiroaki Niitsuma, Hisayoshi Watanabe, Y. Akahane, Hajime Tokita, Takanobu Kato, Yasuhito Tanaka, Etsuro Orito, Ryuzo Ueda, Y. Miyakawa, M Mizokami

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)

    LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC) por R.S. Finn, Masatoshi Kudo, Philippe Merle, Tim Meyer, S. Qin, M. Ikeda, Run-Nan Xu, Julien Edeline, B-Y. Ryoo, Z. Ren, Ann‐Lii Cheng, P.R. Galle, S. Kaneko, H. Kumada, A. Wang, K. Mody, L. Dubrovsky, A.B. Siegel, J. Llovet

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma

    Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma por Richard S. Finn, Masashi Kudo, P. Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruliang Xu, Julien Edeline, B-Y Ryoo, Zhenggang Ren, Ann‐Lii Cheng, Peter R. Galle, Shuichi Kaneko, H. Kumada, S. Kamble, Josephine M. Norquist, Kabir Mody, Andrew Z. Wang, Leonid Dubrovsky, Josep M. Llovet

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results

    A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results por Josep M. Llovet, Karen Shepard, RS Finn, Masafumi Ikeda, Max W. Sung, Ari David Baron, Masatoshi Kudo, Takuji Okusaka, Masahiro Kobayashi, H. Kumada, Shuichi Kaneko, Marc Pracht, K. G Mamontov, Tim Meyer, Kalgi Mody, Tomoki Kubota, Kenichi Saito, A.B. Siegel, Leonid Dubrovsky, Andrew X. Zhu

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: